0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Hemophilia Foundation Recommends Prophylactic Use of Clotting Factors

Andrew A. Skolnick
JAMA. 1994;272(15):1153-1154. doi:10.1001/jama.1994.03520150019005.
Text Size: A A A
Published online

ABSTRACT

EARLY PROPHYLACTIC use of clotting factors in patients with severe hemophilia is gaining acceptance as a way to prevent the pain, morbidity, and mortality associated with bleeding disorders.

Earlier this year, the National Hemophilia Foundation (NHF), New York, NY, adopted recommendations calling on physicians to consider treating young patients with severe hemophilia with appropriate clotting factors three times a week to prevent painful and crippling bleeding episodes.

For its 46th annual meeting in Dallas, Tex, next week, the foundation has scheduled two symposia on new treatment options—one for patients and their families and one for physicians.

The new recommendations are based on extensive clinical research, conducted primarily in Sweden, that shows that early primary prophylaxis may prevent painful and crippling joint damage as well as disabling or fatal brain hemorrhages, says Marilyn Manco-Johnson, MD, director of the Mountain States Regional Hemophilia Center and associate professor of pediatrics, University of Colorado

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();